echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > China Chemical > Bruker acquires Pharma PAT Software and biopharmaceutical manufacturing automation company

    Bruker acquires Pharma PAT Software and biopharmaceutical manufacturing automation company

    • Last Update: 2022-04-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    U.
    S.
    scientific instrumentation supplier Bruker has acquired Optimal Industrial automation and Technologies, a UK-based specialist in pharmaceutical and biopharmaceutical process analysis technology, pharmaceutical manufacturing automation and quality assurance software, and systems integration, the company said a few days ago
    .


    The acquisition strengthens Bruker's position as a key software and solutions provider for small molecule, biologics and new drug model pharmaceutical companies


    Financial details of the acquisition were not disclosed
    .


    Optimal's 2022 revenue is expected to be approximately $10 million, and its revenue growth rate and operating margin are expected to increase in 2023 and beyond


    High-quality biopharmaceutical tools and automation capabilities will enhance Bruker's innovation capabilities and make more differentiated high-value NMR, mass spectrometry, SPR, molecular spectroscopy and other instruments, complement biopharmaceutical drug discovery capabilities and develop new life science solutions solutions, as well as PAT analysis and QA solutions
    .

    These biopharmaceutical tools enable Bruker's global biopharmaceutical customers to bring effective and safe medicines to market faster
    .

    Optimal specializes in the automation and optimization of batch and continuous processes from R&D to manufacturing in the biopharmaceutical industry.


    As a comprehensive PAT solutions provider, Optimal provides the development, testing, deployment and support of quality-focused pharmaceutical production systems



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.